Effect of protein content on the physical stability and microstructure of a model infant formula by McCarthy, N, Gee, V, Hickey, D, Kelly, A, O'Mahony, J, Fenelon, M

MOG-IgG1 antibodies in children by Waters, P, Fadda, G, Woodhalli, M, Irani, S, O'Mahony, J, Brown, R, Castro, D, Longoni, G, Yeh, E, Marrie, R, Arnold, D, Banwell, B, Bar-Or, A

Prospective clinical and MRI characterization of children with serum anti-MOG antibodies meeting the multiple sclerosis diagnostic criteria by Fadda, G, Waters, P, Woodhall, M, Irani, S, Brown, R, O'Mahony, J, Castro, D, Longoni, G, Yeh, E, Marrie, R, Arnold, D, Banwell, B, Bar-Or, A, Dis, C

Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes by Waters, P, Fadda, G, Woodhall, M, O’Mahony, J, Brown, RA, Castro, DA, Longoni, G, Irani, SR, Sun, B, Yeh, EA, Marrie, RA, Arnold, DL, Banwell, B, Bar-Or, A

MRI and laboratory features and the performance of international criteria in the diagnosis of multiple sclerosis in children and adolescents: a prospective cohort study by Fadda, G, Brown, R, Longoni, G, Castro, D, O'Mahony, J, Verhey, L, Branson, H, Waters, P, Bar-Or, A, Marrie, R, Yeh, E, Narayanan, S, Arnold, D, Banwell, B, Canadian Pediatric Demyelinating Disease Network